Developer docs
API playgroundTry for free, no card

Search company profiles

Solace Nutrition

Full company profile

uuid000cror

Namestring
Solace Nutrition
Legal namestring
Solace Nutrition, LLC
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Solace Nutrition, LLC is a medical nutrition company founded in 2006 and headquartered in North Stonington, Connecticut. The company manufactures and distributes medical foods and dietary supplements for patients with rare metabolic disorders, fat malabsorption conditions (including cystic fibrosis and exocrine pancreatic insufficiency), food allergies, and inborn errors of metabolism such as PKU and homocystinuria. Its portfolio spans six product lines: Encala (a proprietary NIH-backed structured-lipid medical food for fat malabsorption), NanoVM (age-segmented hypoallergenic multivitamin and mineral powders), Cyto (mitochondrial support), Metabolics, neoKe (ketogenic support), and SolMods, plus the R-Kane Nutritionals high-protein meal replacement brand acquired in January 2022.

The company's core technology is the Encala structured-lipid formulation (originally Lym-X-Sorb), developed by David Yesair, PhD and manufactured under a partnership with Structured Lipid Nutrition, LLC, founded by Virginia Stallings, MD. Encala was validated through an NIH-funded 110-patient randomized clinical trial in pediatric cystic fibrosis and is supported by eight peer-reviewed publications. Manufacturing is NSF GMP-registered and cGMP-compliant. Products are priced at $59.95 per NanoVM container and $240 per Encala container, with subscribe-and-save options up to 5%. Distribution combines an exclusive DME arrangement with Hearts Enteral for Encala, national medical distributors (Cardinal Health, McKesson, McKesson Medical Surgical), direct e-commerce with international shipping, and toll-free phone ordering with insurance reimbursement support under established HCPCS codes.

Solace generates revenue through direct product sales (one-time and subscription), wholesale distribution, and DME channel fulfillment. The company employs 1-10 staff and is led by CEO Thomas Clough. It is privately held with no disclosed institutional equity funding; the principal R&D investment behind Encala, more than $17 million, has come from NIH grants and Envara Health support rather than from the company's own revenue base.

Short descriptiontext

Solace Nutrition, LLC is a Connecticut-based medical nutrition company that manufactures hypoallergenic medical foods and dietary supplements for patients with rare metabolic disorders, fat malabsorption conditions, and food allergies, distributing via an exclusive DME partner, national medical distributors, and direct e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNorth Stonington, United States
HQ citystring
North Stonington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical nutrition products, medical foods, dietary supplements, metabolic disorder nutrition, hypoallergenic vitamins
Industry5 codes
PRIMARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRADAOAL
Fats, Oils & Lipid Ingredients (Specialty Oils, MCTs, Structured Lipids)
SECONDARYCRADAGAG
Weight Management & Metabolic Supplements
SECONDARYBPADAJAB
Nutrition-Specific Interventions (Micronutrients, Supplementation, Fortification)
NAICS code2 codes
  • Food (Health) Supplement Retailers456191
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Medical Nutrition
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Direct Product Sales
TypeOne Time License
Description

Direct-to-consumer and B2B sales of medical foods and dietary supplements. Products sold through company website, toll-free phone orders, and distributor relationships. Insurance reimbursement available for eligible products through DME or enteral nutrition benefits.

solacenutrition.com
2Wholesale/Distribution Sales
TypeTransaction Fee
Description

Products distributed through national distributors Cardinal Health, McKesson, and McKesson Medical Surgical. DMEs and specialty pharmacies order through business credit accounts.

solacenutrition.com
3DME Distribution Revenue
TypeSubscription Recurring
Description

Exclusive DME partnership with Hearts Enteral for Encala fulfillment and coordination. Insurance-covered products distributed through durable medical equipment channel.

solacenutrition.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details3 tiers
1Encala medical food at $240 per container
ModelSubscriptionBilling cadenceMonthly
Notes

Encala (structured-lipid medical food for fat malabsorption) priced at $240.00 per container. Subscribe and save option available with up to 5% discount (every 1, 3, or 6 months for $228). Product Code 7006, HCPCS Code S9432.

solacenutrition.com
2NanoVM products at $59.95 per container
ModelSubscriptionBilling cadenceMonthly
Notes

NanoVM product lines (t/f, 9-18, Adult, Senior 71+) all priced at $59.95 per container. Subscribe and save option available with up to 5% discount. Net weight 275g per container. HCPCS Code B4104 for tube feeding products.

solacenutrition.com
3Wholesale/distributor pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Products available through national distributors Cardinal Health, McKesson, and McKesson Medical Surgical with specific ordering numbers. Business credit accounts available for DMEs, specialty pharmacies, and hospitals.

solacenutrition.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Encala
Description

Proprietary plant-based structured-lipid medical food designed to address fat malabsorption, fatty acid and choline deficiencies, poor growth in children, and unintentional weight loss in adults.

solacenutrition.com
+5 more records
Core offering1 text field

Solace Nutrition manufactures and distributes medical foods and dietary supplements for individuals with unique metabolic nutritional needs and chronic diseases, including fat malabsorption disorders (cystic fibrosis, EPI), rare inborn errors of metabolism (PKU, HCU, mitochondrial cytopathies), and multiple food allergies. The portfolio is organized across product lines such as Encala (structured-lipid medical food), NanoVM (hypoallergenic vitamin/mineral powders), Cyto (mitochondrial support), Metabolics, neoKe (ketogenic support), and SolMods, plus the acquired R-Kane meal replacement line.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • NIH-funded randomized clinical trial demonstrated clinically meaningful improvements in growth and nutritional status in 110 children with cystic fibrosis
+2 more records
Product overview1 text field

Solace Nutrition is a medical nutrition company offering a portfolio of medical foods and dietary supplements organized across six product lines: Encala (structured-lipid medical food for fat malabsorption), NanoVM (vitamin/mineral supplements across age-specific formulations from infants to seniors), Cyto (mitochondrial support products), Metabolics (metabolic disorder support), neoKe (ketogenic diet support including MCT and BHB products), and SolMods (carbohydrate and probiotic supplements). The company also acquired R-Kane Nutritionals for high-protein meal replacements. Products target rare metabolic conditions including PKU, HCU, cystic fibrosis, EPI, mitochondrial cytopathies, and various inborn errors of metabolism. Most products require medical supervision but do not require a prescription.

Product and service9 records
1Encala
CategoryMedical Food - Fat Malabsorption
Description

Clinically proven, NIH-backed structured-lipid medical food powder designed to enhance fat absorption and nutritional status in patients with fat malabsorption disorders, including cystic fibrosis and exocrine pancreatic insufficiency. Each serving adds 100 calories and 6g of healthy fat.

2NanoVM Vitamin and Mineral Powder Line
CategoryDietary Supplement - Multivitamin/Mineral
Description

Hypoallergenic, ketogenic-friendly vitamin and mineral powder supplements across age-specific formulations (1-3, 4-8, 9-18, Adult, Senior 71+) and a tube-feeding variant (t/f). Each contains 14 vitamins, 13 minerals plus choline using the most bioavailable forms for maximum absorption.

3Cyto Mitochondrial Support Line
CategoryMedical Food - Mitochondrial Support
Description

Product line including Cyto-Q, Cyto-Q MAX, Cyto-Q t/f, Cytotine, Cytotine Powder, Cyto B1, Cyto B2, Cyto B7, Cyto Carn, Cyto RALA, and Cytolline for mitochondrial support. Includes CoQ10 (ubiquinone), B vitamins, L-carnitine, and R-lipoic acid formulations.

4Metabolics Product Line
CategoryMedical Food - Metabolic Disorder Support
Description

Product line including Galaxtra, MannXtra, GlyMax, and VB6 P5P for metabolic disorder management. VB6 P5P is a concentrated vitamin B6 powder containing Pyridoxal 5-Phosphate for Classical HCU and vitamin B6-responsive disorders.

5neoKe Ketogenic Support Line
CategoryMedical Food - Ketogenic Diet Support
Description

Product line including neoKe BCAA4 (branched-chain amino acids), neoKe MCT70 (70% MCT powder), and neoKe BHB (beta-hydroxybutyrate) for ketogenic diet support and epilepsy management.

6SolMods Line
CategoryDietary Supplement - General Nutrition
Description

Product line including PureCarb (carbohydrate supplement), Maltocarb (maltodextrin carbohydrate supplement), and Solace Probiotics for general nutritional supplementation support.

7Cholex Cholesterol Synthesis Support
CategoryMedical Food - Cholesterol Support
Description

Cholextra t/f (tube feeding formulation) and CholexMAX products designed for cholesterol synthesis support in patients with conditions including Smith-Lemli-Opitz syndrome.

8PreKUnil / NeoPhe PKU Management Products
CategoryMedical Food - PKU Management
Description

PreKUnil and NeoPhe (tablets and powder forms) phenylalanine-free, large neutral amino acid (LNAA) medical foods designed for phenylketonuria (PKU) management.

9R-Kane Nutritionals Meal Replacements
CategoryMeal Replacement - Weight Management
Description

High protein meal replacement solutions for the weight loss and management market, including products used in medically-supervised weight loss programs.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Hearts Enteral
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-24
Description

Exclusive DME (Durable Medical Equipment) distribution partnership for Encala medical food. Hearts Enteral provides fulfillment, patient support, insurance coordination, and healthcare provider collaboration. Founded by Raenette Franco with national reputation for compassionate service and clinical expertise.

solacenutrition.com
2Structured Lipid Nutrition, LLC (SLN)
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-01-01
Description

Partnership to manufacture and distribute Encala structured-lipid medical food technology. SLN preserves the Encala technology and clinically recognized brand while Solace provides manufacturing, distribution, and patient support. Founded by Virginia Stallings, MD.

solacenutrition.com
Strategic tierCoreTypeOthers
Description

Funded the original Encala research including large randomized clinical trial led by Dr. Virginia Stallings. Over $17 million invested in Encala development through NIH grant funding and Envara Health support.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

National medical supply distributor for Solace Nutrition products. Distributor ordering numbers provided for DMEs and specialty pharmacies.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

National medical supply distributors for Solace Nutrition products. Ordering numbers provided for product fulfillment through these distribution channels.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medically supervised weight loss and meal replacement programs, including the OPTAVIA and Medifast product lines. Directly comparable to Solace's R-Kane Nutritionals high-protein meal replacement business acquired in 2022.

TypeBroad incumbent
Description

Major medical and clinical nutrition brand with PediaSure, Ensure, Vital, and metabolic disease formulas. Overlaps with Solace across age-specific, hypoallergenic, and tube-feeding nutrition but at substantially larger scale and broader product breadth.

TypeDirect peer
Description

Plant-based, hypoallergenic enteral and tube feeding formulas (including pediatric and adult formulas) prescribed for patients with malabsorption and food allergies. Directly comparable to Solace's NanoVM t/f and Encala clinical nutrition offerings.

TypeBroad incumbent
Description

Parent of Vitaflo and owner of major medical nutrition and consumer health brands. Competes with Solace across metabolic, ketogenic, and clinical nutrition segments as a large, broad-line incumbent.

TypeDirect peer
Description

Global leader in medical nutrition for rare metabolic disorders (PKU, MSUD, HCU, glycine encephalopathy) as well as tube feeding and disease-specific formulas. Directly comparable to Solace on Encala-style metabolic medical foods and on age-specific hypoallergenic nutrition.

TypeEmerging player
Description

Specialty supplement brand focused on digestive enzymes and targeted nutritional products. Adjacent to Solace in the specialty / condition-specific supplement space with overlapping metabolic and digestive health positioning.

TypeDirect peer
Description

Medical nutrition brand within Nestlé Health Science, focused on PKU, MSUD, HCU, glycogen storage disease, and ketogenic dietary therapy. Highly comparable to Solace's Metabolics and neoKe ketogenic product lines and to Encala's disease-specific positioning.

TypeBroad incumbent
Description

Established infant and medical nutrition brand (Enfamil, PurAmino, Nutramigen) covering hypoallergenic, metabolic, and specialty pediatric nutrition. Overlaps with Solace's hypoallergenic pediatric and metabolic formulas.

TypeDirect peer
Description

Specialist medical nutrition company focused on PKU and other inborn errors of metabolism, offering phenylalanine-free amino acid formulas and disease-specific medical foods. Closely overlaps Solace's PreKUnil, NeoPhe, Metabolics, and metabolic medical food portfolio.

TypeBroad incumbent
Description

Medical nutrition business within Ajinomoto, focused on disease-specific medical foods for rare metabolic conditions. Comparable to Solace's metabolic medical food portfolio and structured-lipid / Encala adjacency.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Solace Nutrition

Medical Nutritionsolacenutrition.com

Solace Nutrition, LLC is a Connecticut-based medical nutrition company that manufactures hypoallergenic medical foods and dietary supplements for patients with rare metabolic disorders, fat malabsorption conditions, and food allergies, distributing via an exclusive DME partner, national medical distributors, and direct e-commerce.

What Solace Nutrition does

Solace Nutrition, LLC is a medical nutrition company founded in 2006 and headquartered in North Stonington, Connecticut. The company manufactures and distributes medical foods and dietary supplements for patients with rare metabolic disorders, fat malabsorption conditions (including cystic fibrosis and exocrine pancreatic insufficiency), food allergies, and inborn errors of metabolism such as PKU and homocystinuria. Its portfolio spans six product lines: Encala (a proprietary NIH-backed structured-lipid medical food for fat malabsorption), NanoVM (age-segmented hypoallergenic multivitamin and mineral powders), Cyto (mitochondrial support), Metabolics, neoKe (ketogenic support), and SolMods, plus the R-Kane Nutritionals high-protein meal replacement brand acquired in January 2022.

The company's core technology is the Encala structured-lipid formulation (originally Lym-X-Sorb), developed by David Yesair, PhD and manufactured under a partnership with Structured Lipid Nutrition, LLC, founded by Virginia Stallings, MD. Encala was validated through an NIH-funded 110-patient randomized clinical trial in pediatric cystic fibrosis and is supported by eight peer-reviewed publications. Manufacturing is NSF GMP-registered and cGMP-compliant. Products are priced at $59.95 per NanoVM container and $240 per Encala container, with subscribe-and-save options up to 5%. Distribution combines an exclusive DME arrangement with Hearts Enteral for Encala, national medical distributors (Cardinal Health, McKesson, McKesson Medical Surgical), direct e-commerce with international shipping, and toll-free phone ordering with insurance reimbursement support under established HCPCS codes.

Solace generates revenue through direct product sales (one-time and subscription), wholesale distribution, and DME channel fulfillment. The company employs 1-10 staff and is led by CEO Thomas Clough. It is privately held with no disclosed institutional equity funding; the principal R&D investment behind Encala, more than $17 million, has come from NIH grants and Envara Health support rather than from the company's own revenue base.

Solace Nutrition firmographics

Firmographics
Name
Solace Nutrition
Legal name
Solace Nutrition, LLC
Website
https://solacenutrition.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
1–10 employees
Short description
Solace Nutrition, LLC is a Connecticut-based medical nutrition company that manufactures hypoallergenic medical foods and dietary supplements for patients with rare metabolic disorders, fat malabsorption conditions, and food allergies, distributing via an exclusive DME partner, national medical distributors, and direct e-commerce.
Ownership category
akta.pro rank

Solace Nutrition industry classification

Industry
Product category
Medical Nutrition
NAICS
Food (Health) Supplement Retailers (456191), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro industry
PRIMARYCRADAGAN
Medical Nutrition & Meal Replacement (RTD, Bars, Powders)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRADAOAL
Fats, Oils & Lipid Ingredients (Specialty Oils, MCTs, Structured Lipids)
SECONDARYCRADAGAG
Weight Management & Metabolic Supplements
SECONDARYBPADAJAB
Nutrition-Specific Interventions (Micronutrients, Supplementation, Fortification)

Keywords

  • Medical nutrition products
  • Medical foods
  • Dietary supplements
  • Metabolic disorder nutrition
  • Hypoallergenic vitamins

Where Solace Nutrition is headquartered

Location

Headquarters

HQ city
North Stonington
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Solace Nutrition business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Direct Product Sales: Direct-to-consumer and B2B sales of medical foods and dietary supplements. Products sold through company website, toll-free phone orders, and distributor relationships. Insurance reimbursement available for eligible products through DME or enteral nutrition benefits.
  2. Wholesale/Distribution Sales: Products distributed through national distributors Cardinal Health, McKesson, and McKesson Medical Surgical. DMEs and specialty pharmacies order through business credit accounts.
  3. DME Distribution Revenue: Exclusive DME partnership with Hearts Enteral for Encala fulfillment and coordination. Insurance-covered products distributed through durable medical equipment channel.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyEncala medical food at $240 per container
SubscriptionMonthlyNanoVM products at $59.95 per container
OtherPay-as-you-goWholesale/distributor pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Solace Nutrition product offering

Product offering

Core offering

Solace Nutrition manufactures and distributes medical foods and dietary supplements for individuals with unique metabolic nutritional needs and chronic diseases, including fat malabsorption disorders (cystic fibrosis, EPI), rare inborn errors of metabolism (PKU, HCU, mitochondrial cytopathies), and multiple food allergies. The portfolio is organized across product lines such as Encala (structured-lipid medical food), NanoVM (hypoallergenic vitamin/mineral powders), Cyto (mitochondrial support), Metabolics, neoKe (ketogenic support), and SolMods, plus the acquired R-Kane meal replacement line.

Product overview

Solace Nutrition is a medical nutrition company offering a portfolio of medical foods and dietary supplements organized across six product lines: Encala (structured-lipid medical food for fat malabsorption), NanoVM (vitamin/mineral supplements across age-specific formulations from infants to seniors), Cyto (mitochondrial support products), Metabolics (metabolic disorder support), neoKe (ketogenic diet support including MCT and BHB products), and SolMods (carbohydrate and probiotic supplements). The company also acquired R-Kane Nutritionals for high-protein meal replacements. Products target rare metabolic conditions including PKU, HCU, cystic fibrosis, EPI, mitochondrial cytopathies, and various inborn errors of metabolism. Most products require medical supervision but do not require a prescription.

Differentiator

Problem solved

Functional benefit

Brands

  • Encala: Proprietary plant-based structured-lipid medical food designed to address fat malabsorption, fatty acid and choline deficiencies, poor growth in children, and unintentional weight loss in adults.
  • NanoVM
  • Cyto
  • Metabolics
  • neoKe
  • SolMods

Products and services

  • Encala Clinically proven, NIH-backed structured-lipid medical food powder designed to enhance fat absorption and nutritional status in patients with fat malabsorption disorders, including cystic fibrosis and exocrine pancreatic insufficiency. Each serving adds 100 calories and 6g of healthy fat.
  • NanoVM Vitamin and Mineral Powder Line Hypoallergenic, ketogenic-friendly vitamin and mineral powder supplements across age-specific formulations (1-3, 4-8, 9-18, Adult, Senior 71+) and a tube-feeding variant (t/f). Each contains 14 vitamins, 13 minerals plus choline using the most bioavailable forms for maximum absorption.
  • Cyto Mitochondrial Support Line Product line including Cyto-Q, Cyto-Q MAX, Cyto-Q t/f, Cytotine, Cytotine Powder, Cyto B1, Cyto B2, Cyto B7, Cyto Carn, Cyto RALA, and Cytolline for mitochondrial support. Includes CoQ10 (ubiquinone), B vitamins, L-carnitine, and R-lipoic acid formulations.
  • Metabolics Product Line Product line including Galaxtra, MannXtra, GlyMax, and VB6 P5P for metabolic disorder management. VB6 P5P is a concentrated vitamin B6 powder containing Pyridoxal 5-Phosphate for Classical HCU and vitamin B6-responsive disorders.
  • neoKe Ketogenic Support Line Product line including neoKe BCAA4 (branched-chain amino acids), neoKe MCT70 (70% MCT powder), and neoKe BHB (beta-hydroxybutyrate) for ketogenic diet support and epilepsy management.
  • SolMods Line Product line including PureCarb (carbohydrate supplement), Maltocarb (maltodextrin carbohydrate supplement), and Solace Probiotics for general nutritional supplementation support.
  • Cholex Cholesterol Synthesis Support Cholextra t/f (tube feeding formulation) and CholexMAX products designed for cholesterol synthesis support in patients with conditions including Smith-Lemli-Opitz syndrome.
  • PreKUnil / NeoPhe PKU Management Products PreKUnil and NeoPhe (tablets and powder forms) phenylalanine-free, large neutral amino acid (LNAA) medical foods designed for phenylketonuria (PKU) management.
  • R-Kane Nutritionals Meal Replacements High protein meal replacement solutions for the weight loss and management market, including products used in medically-supervised weight loss programs.

Quantifiable outcome

  • NIH-funded randomized clinical trial demonstrated clinically meaningful improvements in growth and nutritional status in 110 children with cystic fibrosis
  • +2 more outcomes

Companies that use Solace Nutrition

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Solace Nutrition technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Solace Nutrition partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Hearts EnteralcoreChannel Partner/ Reseller/ Distributor · 24 February 2026Exclusive DME (Durable Medical Equipment) distribution partnership for Encala medical food. Hearts Enteral provides fulfillment, patient support, insurance coordination, and healthcare provider collaboration. Founded by Raenette Franco with national reputation for compassionate service and clinical expertise.
  • Structured Lipid Nutrition, LLC (SLN)coreOEM/ Whitelabel/ Licensing Partner · 1 January 2024Partnership to manufacture and distribute Encala structured-lipid medical food technology. SLN preserves the Encala technology and clinically recognized brand while Solace provides manufacturing, distribution, and patient support. Founded by Virginia Stallings, MD.
  • NIH (National Institutes of Health)coreOthersFunded the original Encala research including large randomized clinical trial led by Dr. Virginia Stallings. Over $17 million invested in Encala development through NIH grant funding and Envara Health support.
  • Cardinal HealthminorChannel Partner/ Reseller/ DistributorNational medical supply distributor for Solace Nutrition products. Distributor ordering numbers provided for DMEs and specialty pharmacies.
  • McKesson / McKesson Medical SurgicalminorChannel Partner/ Reseller/ DistributorNational medical supply distributors for Solace Nutrition products. Ordering numbers provided for product fulfillment through these distribution channels.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Solace Nutrition competitors and assessment

Company assessment

Direct peers

  • Medifast: Medically supervised weight loss and meal replacement programs, including the OPTAVIA and Medifast product lines. Directly comparable to Solace's R-Kane Nutritionals high-protein meal replacement business acquired in 2022.
  • Kate Farms: Plant-based, hypoallergenic enteral and tube feeding formulas (including pediatric and adult formulas) prescribed for patients with malabsorption and food allergies. Directly comparable to Solace's NanoVM t/f and Encala clinical nutrition offerings.
  • Nutricia (Danone): Global leader in medical nutrition for rare metabolic disorders (PKU, MSUD, HCU, glycine encephalopathy) as well as tube feeding and disease-specific formulas. Directly comparable to Solace on Encala-style metabolic medical foods and on age-specific hypoallergenic nutrition.
  • Vitaflo (Nestlé Health Science): Medical nutrition brand within Nestlé Health Science, focused on PKU, MSUD, HCU, glycogen storage disease, and ketogenic dietary therapy. Highly comparable to Solace's Metabolics and neoKe ketogenic product lines and to Encala's disease-specific positioning.
  • Cambrooke Therapeutics: Specialist medical nutrition company focused on PKU and other inborn errors of metabolism, offering phenylalanine-free amino acid formulas and disease-specific medical foods. Closely overlaps Solace's PreKUnil, NeoPhe, Metabolics, and metabolic medical food portfolio.

Broad incumbents

  • Abbott Nutrition: Major medical and clinical nutrition brand with PediaSure, Ensure, Vital, and metabolic disease formulas. Overlaps with Solace across age-specific, hypoallergenic, and tube-feeding nutrition but at substantially larger scale and broader product breadth.
  • Nestlé Health Science: Parent of Vitaflo and owner of major medical nutrition and consumer health brands. Competes with Solace across metabolic, ketogenic, and clinical nutrition segments as a large, broad-line incumbent.
  • Mead Johnson Nutrition (Reckitt): Established infant and medical nutrition brand (Enfamil, PurAmino, Nutramigen) covering hypoallergenic, metabolic, and specialty pediatric nutrition. Overlaps with Solace's hypoallergenic pediatric and metabolic formulas.
  • Ajinomoto Cambrooke (Applied Nutrition): Medical nutrition business within Ajinomoto, focused on disease-specific medical foods for rare metabolic conditions. Comparable to Solace's metabolic medical food portfolio and structured-lipid / Encala adjacency.

Emerging players

  • Enzymedica: Specialty supplement brand focused on digestive enzymes and targeted nutritional products. Adjacent to Solace in the specialty / condition-specific supplement space with overlapping metabolic and digestive health positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Solace Nutrition social profiles

Digital presence

Solace Nutrition compliance and trust

Trust signal

Compliance2 records

Solace Nutrition financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Solace Nutrition leadership team

Management profile

Number of profiles

Profiles2 records

Solace Nutrition subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Solace Nutrition funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Solace Nutrition M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solace Nutrition

What does Solace Nutrition do?

Solace Nutrition manufactures and distributes medical foods and dietary supplements for individuals with unique metabolic nutritional needs and chronic diseases, including fat malabsorption disorders (cystic fibrosis, EPI), rare inborn errors of metabolism (PKU, HCU, mitochondrial cytopathies), and multiple food allergies. The portfolio is organized across product lines such as Encala (structured-lipid medical food), NanoVM (hypoallergenic vitamin/mineral powders), Cyto (mitochondrial support), Metabolics, neoKe (ketogenic support), and SolMods, plus the acquired R-Kane meal replacement line.

Is Solace Nutrition a public or private company?

Solace Nutrition is a private company. It is classified as family owned and is currently operating.

When was Solace Nutrition founded?

Solace Nutrition was founded in 2006. It employs 1 to 10 people.

Where is Solace Nutrition based?

Solace Nutrition is headquartered in North Stonington, United States, in the North America region.

How does Solace Nutrition make money?

Three revenue lines are on record. Direct Product Sales are the primary driver. The others are wholesale/Distribution Sales and DME Distribution Revenue.

Who are Solace Nutrition's main competitors?

Direct peers on record are Medifast, Kate Farms, Nutricia (Danone), Vitaflo (Nestlé Health Science) and Cambrooke Therapeutics. Broad incumbents are Abbott Nutrition, Nestlé Health Science, Mead Johnson Nutrition (Reckitt) and Ajinomoto Cambrooke (Applied Nutrition). Enzymedica is listed as an emerging player.

Does Solace Nutrition have an API?

No public API is recorded for Solace Nutrition.

What industry is Solace Nutrition in?

Solace Nutrition's product category is Medical Nutrition. Its primary akta.pro industry code is CRADAGAN, Medical Nutrition & Meal Replacement (RTD, Bars, Powders), with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 456191 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSolace Nutrition Announces Clinical and Scientific Updates for Encala®, the Original Structured-Lipid Medical Food for Fat MalabsorptionSolace Nutrition announced significant clinical, scientific, and commercial updates for Encala®, its proprietary structured-lipid medical food for fat malabsorption, reporting that sales have exceeded projections since the February 2025 relaunch. The company outlined international expansion plans starting with Canada in Q3 2026 and South America by Q4 2026, alongside multiple ongoing clinical studies including a Department of Defense-funded pancreatic cancer trial and a pending cerebral palsy study. More than $17 million has been invested in Encala's development through NIH grant funding and Envara Health support, with the product now incorporated into the NDSR clinical research software.PR NewswireWeight Loss Supplements Global Market Report 2022The global weight loss supplements market is projected to grow from $30.12 billion in 2021 to $34.19 billion in 2022 at a 13.51% CAGR, reaching $55.41 billion by 2026, driven by rising obesity rates worldwide. Asia-Pacific was the largest and fastest-growing region in 2021, with major companies increasingly focusing on innovative product development using natural ingredients and new production technologies. In January 2022, Solace Nutrition, a US-based medical nutrition company, acquired the assets of R-Kane Nutritionals, another US-based company specializing in high protein meal replacement products for weight management.PR NewswireThe Rise In Obesity Rates Is Expected To Drive The Weight Loss Supplement Market To $55 Billion By 2026The Business Research Company projects the global weight loss supplements market to grow from $30.12 billion in 2021 to $55.41 billion by 2026 at a CAGR of 12.83%, driven by rising obesity rates with over 1 billion people globally now obese. The report identifies technological advancement and innovative product development as a key trend among market players. In January 2022, Solace Nutrition, a USA-based medical nutrition company, acquired the assets of R-Kane Nutritionals to expand its presence in the weight management nutrition market.PR NewswireSOLACE NUTRITION, LLC ACQUIRES R-KANE NUTRITIONALSSolace Nutrition, LLC has acquired the assets of R-Kane Nutritionals, LLC, a company specializing in high protein meal replacement solutions for weight loss and management. This transaction represents a strategic extension for Solace into an adjacent medically supervised nutrition market, aiming to create synergies and accelerate growth through shared manufacturing and distribution capabilities.